Skip to content

First 100 Claimants Earn Genesis Founder Badge

Are you with MicroPort MedBot (Group)?

1,221companies listed

MicroPort MedBot (Group)

ChinaFounded 2015

the only surgical robot company in the world with businesses covering six promising subsectors of surgical robots including endoscopy, orthopedics, vascular intervention, natural orifice surgery, percutaneous puncture and medical aesthetics

MicroPort MedBot (Shanghai MicroPort MedBot Group Co., Ltd.; HKEX: 02252) develops surgical robots across endoscopy (Toumai), orthopedics, vascular intervention (R-ONE), natural orifice surgery, percutaneous puncture, and medical aesthetics. R-ONE, a JV with Robocath via Cathbot, is the world's first dual-finger grasp mimic vascular intervention robot approved in China for PCI procedures. Operates in China, Bangladesh, with CE mark for R-One in Europe. Targets hospitals for minimally invasive cardiovascular and endoscopic interventions.

Company facts

Legal name
MicroPort MedBot (Group) Co., Ltd.
HQ
Shanghai, China
Founded
2015 · 11 yrs
Stage
unknown

Trusted by

Milestones

  1. R-ONE vascular intervention robot performed complex procedures in Bangladesh

  2. R-ONE vascular intervention robot received NMPA approval in China

  3. Completed first robotic coronary angioplasty with R-One in China at 301 Hospital

Press coverage

Active products by MicroPort MedBot (Group)

2 shown

Where will these robots operate? Often the same as your country — add more for multi-country deployments.

Surgical / Medical buying guides

Industry Knowledge →